61 results
8-K
EX-10.1
RYTM
Rhythm Pharmaceuticals Inc.
1 Apr 24
Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing
5:25pm
extensions thereof and has paid all taxes required to be paid by it and any other assessment, fine or penalty levied against it, to the extent that any … of the foregoing is due and payable, except (i) for any such assessment, fine or penalty that is currently being contested in good faith or (ii
8-K
RYTM
Rhythm Pharmaceuticals Inc.
22 Feb 24
Rhythm Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Business Update
7:01am
(the “Annual Report”). We have not yet completed our assessment of our internal control over financial reporting and the following material weakness … is subject to change upon completion of such assessment, which may also result in additional or different material weaknesses. Our independent registered
8-K
EX-99.1
aofh4
2 May 23
Rhythm Pharmaceuticals Reports First Quarter 2023 Financial Results and Business Update
7:05am
8-K
EX-99.1
mknbf4 z793dfxghu7
8 Nov 22
Rhythm Pharmaceuticals Reports Third Quarter 2022 Financial Results and Business Update
7:03am
8-K
EX-1.1
xthp2 m0yknptrp7t
15 Sep 22
Other Events
4:02pm
8-K
EX-99.1
2mbd4m5b21udhd e3
6 Apr 22
Regulation FD Disclosure
8:01am
S-3
EX-1.2
scaiafht 3uqslr
2 Nov 21
Shelf registration
5:21pm